Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 1578 for “"mtor"”.
-
Activation of the Akt/mTOR Pathway and the Effects of Increased Myometrial mTOR Signaling During Pregnancy
… Prior research has shown that the P13K/Akt/mTOR signaling pathway is related to birth timing in mouse models (Hirota et al 2011). It has also been shown that rapamycin, an inhibitor of mTOR, can rescue preterm labor in these mouse models (Hirota et al 2011). In this study, western blots were …
-
The PI3K-AKT-MTOR signal transduction pathway and PI3K/MTOR inhibition in canine osteosarcoma and lymphoma
… (AKT), and mechanistic target of rapamycin (mTOR), collectively known as the PI3K-AKT-mTOR pathway, which contributes to disease progression and poorer outcomes. In human medicine, there have been many attempts to induce cessation of signal transduction with halting progress due to the …
-
DPYSL2 and mTOR Signaling in Schizophrenia
… SZ risk and disrupts regulation of the gene by mTOR signaling pathway. Given the biological relevance of DPYSL2 to schizophrenia, the aim of my thesis, composed of three separate investigations, was to further explore the molecular mechanisms on which variations in DPYSL2 contribute risks for …
-
Mathematical Modelling mTOR-NMT Signalling Pathway
Since mammalian target of rapamycin (mTOR) and N-myristoltransferase (NMT) have been shown to be potentially related to breast cancer, mTOR-NMT signalling pathway is taken into specific consideration. In this thesis, mathematical models are developed to not only describe the mTORNMT signalling …
-
Molecular Mechanism of mTOR downstream signaling
The mammalian target of rapamycin, mTOR, is a Ser/Thr kinase that promotes cell growth and proliferation by activating S6 kinases 1 and 2 (S6K1/2), and by inhibiting the translational repressors, eukaryotic initiation factor 4E (eIF4E) binding proteins 1, -2, and -3 (4E-BP1/2/3). The molecular …
-
Role of mTOR in coronavirus replication
… as critical for coronaviruses (CoVs) was the mTOR complex. This pathway was selected for further investigation due to its established role in various viral infections, as well as the availability of multiple well-characterized inhibitors, which have a longstanding clinical use in the treatment …
-
The role of mTOR in mitochondrial disease
… of the mechanistic target of rapamycin (mTOR), a master intracellular nutrient sensing-signaling kinase complex, with rapamycin significantly attenuates disease in multiple GMD models. In particular, rapamycin treatment attenuates neurodegeneration, metabolic dysfunction, and …
-
Regulation of pol III transcription by mTOR
… for pol III regulation. A primary target was the mTOR pathway, as it coordinates nutrient availability with cell growth. Addition of the mTOR inhibitor rapamycin resulted in a decrease in the level of pol III transcripts. Furthermore, inhibition of the mTOR pathway resulted in a decrease in the …
-
Control of Cell Cycle Progression by mTOR
… activated in human cancers is mediated by mTOR -the mammalian target of rapamycin. mTOR is a critical nutrient and energy sensor in cells that lets the cell know that there is sufficient material available for a cell to double its mass and divide. mTOR causes the phosphorylation of …
-
The Role of mTOR in Cardiac Function
… is the protein, mechanistic target of rapamycin (mTOR), a key signaling kinase for most cell types. Overexpression of mTOR has been previously shown by our lab as sufficient to protect the heart against different stressors including ischemia-reperfusion (I/R) injury, TAC-induced hypertrophy, and …
-
Targeting mTOR to Reverse Age-Associated Periodontal Disease
… 2013;Kaeberlein et al. 2015). The FDA approved mTOR inhibitor, rapamycin, represents an outstanding candidate for such an intervention. The field of Geroscience, which seeks to understand how aging causes disease and develop preventative and therapeutic approaches, has shown that this …
-
The effects of mTOR inhibition in ischemic stroke
… is the mammalian target of rapamycin complex 1 (mTORC1), a key regulator of the cells' energy supply, which can be modulated pharmacologically through rapamycin and non-pharmacologically through dietary intervention. The overarching aim of this thesis was to investigate the therapeutic potential …
-
Targeting the PHGDH-mTOR Metabolic Axis in Osteosarcoma
… accumulation resulted in an activation of the mTORC1 signaling pathway, likely as a cellular attempt to supplement the nutrients no longer provided by the SGOC pathways.The second research aim focused on targeting the metabolic pathways induced by PHGDH inhibition. Previous studies in cancers …
-
Resistance mechanisms to mTOR inhibition in renal cancer
… target is the mammalian target of rapamycin (mTOR) and two rapalogues (everolimus and temsirolimus) have been licensed for the treatment of advanced CCRCC, but resistance to treatment is a significant problem. Novel mTOR kinase inhibitors show more complete blockade of mTOR downstream targets, …
-
mTOR signalling and the regulation of Hoxp3 expression
… TGFβ, as well as the inhibition of the kinase mTOR, have been shown to be crucial for the induction of FOXP3 in the peripheral immune system. Despite recent progress, the molecular mechanisms for induction of FOXP3 remains elusive due, at least in part, to the lack of a cell line that mimics …
-
mTOR regulates Aurora A via enhancing protein stability
Mammalian target of rapamycin (mTOR) is a key regulator of protein synthesis. Dysregulation of mTOR signaling occurs in many human cancers and its inhibition causes arrest at the G1 cell cycle stage. However, mTOR’s impact on mitosis (M-phase) is less clear. Here, suppressing mTOR activity impacted …
-
Investigating PI3K/AKT/mTOR signalling in pancreatobiliary cancer
Abstract not currently available.
-
The regulation of pol III transcription by mTOR
… under the control of the PI3K and mammalian TOR (mTOR) pathways. Levels of pol III transcripts were reduced in vivo and pol III transcription was reduced in vitro in response to inhibition of the pathways. Inhibition of the mTOR and PI3K pathways was not found to alter the abundance of the pol …
Page 1 of 79